Paragon Care Limited
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provi… Read more
Paragon Care Limited (PXS) - Net Assets
Latest net assets as of June 2024: €695.47 Million EUR
Based on the latest financial reports, Paragon Care Limited (PXS) has net assets worth €695.47 Million EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.75 Billion) and total liabilities (€1.06 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €695.47 Million |
| % of Total Assets | 39.64% |
| Annual Growth Rate | 31.97% |
| 5-Year Change | 159.99% |
| 10-Year Change | 1318.21% |
| Growth Volatility | 80.27 |
Paragon Care Limited - Net Assets Trend (2014–2024)
This chart illustrates how Paragon Care Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Paragon Care Limited (2014–2024)
The table below shows the annual net assets of Paragon Care Limited from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | €291.92 Million | +15.86% |
| 2023-06-30 | €251.96 Million | +3.97% |
| 2022-06-30 | €242.34 Million | +99.42% |
| 2021-06-30 | €121.52 Million | +8.23% |
| 2020-06-30 | €112.28 Million | -41.62% |
| 2019-06-30 | €192.32 Million | +13.03% |
| 2018-06-30 | €170.14 Million | +105.76% |
| 2017-06-30 | €82.69 Million | +13.63% |
| 2016-06-30 | €72.77 Million | +253.54% |
| 2015-06-30 | €20.58 Million | +13.05% |
| 2014-06-30 | €18.21 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Paragon Care Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3175838100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €328.16 Million | 112.42% |
| Total Equity | €291.92 Million | 100.00% |
Paragon Care Limited Competitors by Market Cap
The table below lists competitors of Paragon Care Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FTC Solar Inc
NASDAQ:FTCI
|
$52.88 Million |
|
Topps Tiles Plc
PINK:TPTJF
|
$52.89 Million |
|
Zomedica Pharmaceuticals Corp
NYSE MKT:ZOM
|
$52.89 Million |
|
Hi Sun Technology (China) Limited
PINK:HISNF
|
$52.90 Million |
|
Kinetic Group Inc
PINK:KNIT
|
$52.84 Million |
|
Acconeer AB
ST:ACCON
|
$52.83 Million |
|
Tainan Enterprises Co Ltd
TW:1473
|
$52.82 Million |
|
Neo Corporate Pcl
BK:NEO
|
$52.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Paragon Care Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 242,849,000 to 291,918,000, a change of 49,069,000 (20.2%).
- Net income of 8,381,000 contributed positively to equity growth.
- Dividend payments of 12,613,000 reduced retained earnings.
- Other factors increased equity by 53,301,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €8.38 Million | +2.87% |
| Dividends Paid | €12.61 Million | -4.32% |
| Other Changes | €53.30 Million | +18.26% |
| Total Change | €- | 20.21% |
Book Value vs Market Value Analysis
This analysis compares Paragon Care Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.57x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.20x to 0.57x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | €0.50 | €0.10 | x |
| 2018-06-30 | €0.60 | €0.10 | x |
| 2019-06-30 | €0.57 | €0.10 | x |
| 2020-06-30 | €0.33 | €0.10 | x |
| 2021-06-30 | €0.36 | €0.10 | x |
| 2022-06-30 | €0.52 | €0.10 | x |
| 2023-06-30 | €0.37 | €0.10 | x |
| 2024-06-30 | €0.18 | €0.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Paragon Care Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.87%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.28%
- • Asset Turnover: 2.63x
- • Equity Multiplier: 3.87x
- Recent ROE (2.87%) is above the historical average (-1.26%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 5.96% | 5.59% | 0.72x | 1.48x | €-735.94K |
| 2015 | 10.22% | 6.53% | 0.79x | 1.97x | €44.80K |
| 2016 | 10.35% | 8.07% | 0.63x | 2.03x | €253.50K |
| 2017 | 12.30% | 8.69% | 0.71x | 2.01x | €1.91 Million |
| 2018 | 6.44% | 8.02% | 0.39x | 2.06x | €-6.06 Million |
| 2019 | -7.48% | -6.09% | 0.61x | 2.00x | €-33.62 Million |
| 2020 | -68.82% | -33.35% | 0.79x | 2.60x | €-88.50 Million |
| 2021 | 6.81% | 3.51% | 0.81x | 2.40x | €-3.87 Million |
| 2022 | 3.03% | 2.88% | 0.57x | 1.85x | €-16.46 Million |
| 2023 | 4.43% | 3.50% | 0.69x | 1.85x | €-13.52 Million |
| 2024 | 2.87% | 0.28% | 2.63x | 3.87x | €-20.81 Million |
Industry Comparison
This section compares Paragon Care Limited's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,490,300,580,058
- Average return on equity (ROE) among peers: -105.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Paragon Care Limited (PXS) | €695.47 Million | 5.96% | 1.52x | $52.86 Million |
| KIMIA FARMA -B- (HQP) | $5.89 Trillion | 5.13% | 1.93x | $78.59 Million |
| Asker Healthcare Group AB (I88) | $3.50 Billion | 10.28% | 2.75x | $1.37 Billion |
| TELES Informationstechnologien AG (TLIK) | $379.23K | -446.97% | 3.69x | $801.14K |
| Sinopharm Group Co. Ltd (X2S) | $68.28 Billion | 8.55% | 2.45x | $3.27 Billion |